Tag: pharmaceuticals

  • Foundation, Company Partner on Diabetes Clinical Study

    The Juvenile Diabetes Research Foundation (JDRF) in New York, N.Y. and Amylin Pharmaceuticals Inc. in San Diego, California said today they entered into an agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of Amylin’s metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers…

  • New iPhone App Offers HIV Drug Info

    University of Liverpool in the U.K. has released an iPhone application (app), — HIV iChart — that provides access to information about drug interactions for both health care professionals and HIV patients. The HIV iChart app is based on the university’s HIV drug Web site that offers a comprehensive resource on potential drug interactions between…

  • Company, Institute Collaborate on Targeted Drug Formulations

    Milestone Scientific Inc. in Livingston, New Jersey and Ordway Research Institute in Albany, New York have agreed to develop drug formulations for precise targeted delivery of drugs to affected body parts, organs, and cancerous tissue through Milestone’s CompuFlo injection technology. Milestone Scientific is a developer of computer-controlled drug delivery technologies and Ordway is a research…

  • Pre-Clinical Data Support Cancer Stem Cell Drug

    Geron Corporation in Menlo Park, California said today two studies with preclinical data demonstrate that the company’s telomerase inhibitor drug imetelstat (GRN163L) targets cancer stem cells from multiple myeloma, pancreatic, and breast cancers. Imetelstat is currently in Phase 2 clinical trials. The company says imetelstat targets cancer stem cells, found in many types of cancer,…

  • FDA Designates Orphan Drug Made From Tarantula Venom

    The U.S. Food and Drug Administration (FDA) has designated the peptide GsMTx4, made by Rose Pharmaceuticals of Buffalo, New York, as an orphan drug for Duchenne muscular dystrophy. Rose Pharmaceuticals is a one-year old company founded by University at Buffalo (UB) medical professor Frederick Sachs and Buffalo stockbroker Jeff Harvey. While Sachs (pictured left) applied…

  • Researchers Discover Workings of Anti-Parasitic Drug

    Scientists have determined the way an anti-parasitic drug kills the Brugia malayi worms (illustrated right) brought on by the filarial diseases river blindness and elephantiasis, a discovery that took decades of research. The diseases afflict about 140 million people worldwide, doing much of their damage in equatorial Africa. Charles Mackenzie, a professor of veterinary pathology…

  • Institutions, Companies Form Psychiatric Trial Database

    An international academic-industry collaboration brings together data on 23,401 anonymous patients from 67 trials on 11 compounds in over 25 countries, to form the largest database of clinical trial data ever created in psychiatric research. The project known as NEWMEDS — Novel Methods leading to NeW MEdications in Depression and Schizophrenia — is led by…

  • Mass. Biotechs Give Postdocs a Look at Business

    The business Web site Xconomy today tells about a year-old program for postdoctoral researchers at Massachusetts General Hospital in Boston that gives postdocs a first-hand look at biotechnology and pharmaceutical companies. In Xconomy, Sylvia Pagán Westphal tells about Mass. General’s Post Doc Industry Experience Program. Westphal says there are some 1,100 labs affiliated with Mass.…

  • Phase 3 Results Boost Rheumatoid Arthritis Drug

    Results from a Phase 3 clinical trial show the drug tasocitinib made by Pfizer Inc. in New York, New York met two out of three end-points for treating rheumatoid arthritis (RA). Tasocitinib is an oral Janus kinase inhibitor for treating RA that targets the intracellular signaling pathways operating as hubs in the inflammatory cytokine network.…

  • Dengue Vaccine in Phase 3 Clinical Trial

    Sanofi Pasteur, the vaccines division of the French pharmaceutical company Sanofi-Aventis, says that its dengue vaccine is in the final stage of clinical development — its first phase 3 clinical study in Australia. Phase 3 trials involve large groups of patients to confirm a drug’s effectiveness, monitor side effects, and compare it to commonly used…